Table I. Drugs applied against lung carcinoma. The first column contains FDA-approved drugs against non-small cell lung cancer (58 drugs). The second column contains a subset of the drugs from the first column after removing duplicated ones (25 drugs). The third column contains drugs that were applied to lung squamous cell carcinoma patients in TCGA (16 drugs). The drugs marked in bold are found both in the second and third column. Eight of sixteen drugs applied to lung squamous cell carcinoma patients in the TCGA panel were FDA-approved.

According to https://www.cancer.org/cancer/non-small-cell-lung-cancer/about/what-is-non-small-cell-lung-cancer.html, lung squamous cell carcinoma is a sub-type of non-small cell lung cancer.